Novartis says US regulator grants speedy review of CAR-T cell therapy – Fox News
Fox News |
Novartis says US regulator grants speedy review of CAR–T cell therapy
Fox News ZURICH – Novartis AG on Wednesday said the U.S. Food and Drug Administration (FDA) has agreed to accelerate its review of the Swiss drugmaker's CTL019 therapy for young patients with B-cell acute lymphoblastic leukemia. The move would keep … Novartis gets speedy review for CAR–T cell therapy Novartis Makes Plans For Its Cancer-Killing T Cells Novartis announces first CAR–T cell therapy BLA for pediatric and young adult patients with r/r B-cell ALL granted … |
